:: Library Catalog

Saved in:

Bibliographic Details
Main Authors:	Marieke Verkleij, Berber Vlieg‐Boerstra, Geesje H. Hofsteenge, Eric Haarman, Jos Twisk, Alexandra L. Quittner, Tim de Meij
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pediatric Pulmonology
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/ppul.71021
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis
by: Lauren N. Kormelink, et al.
Published: (2024)

Multidimensional Impacts of Elexacaftor/Tezacaftor/Ivacaftor: Comparisons of Physical and Mental Health Providers' Observations in Cystic Fibrosis in Europe and the United States
by: Sonia Graziano, et al.
Published: (2025)

Advancing Mental Healthcare for Individuals With Cystic Fibrosis in Low‐ and Middle‐Income Countries
by: Alexandra L. Quittner, et al.
Published: (2026)

Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
by: Elizabeth Clarke, et al.
Published: (2024)

Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis
by: Burcu Uzunoglu, et al.
Published: (2025)

Preliminary Psychometric Characteristics of the Cystic Fibrosis Coping Self‐Efficacy (CF‐CSE) Scale
by: Deborah Friedman, et al.
Published: (2025)

Qualitative Experiences and Depression/Anxiety Scores in Parents of Children With Cystic Fibrosis Transmembrane Conductance Regulator Related Metabolic Syndrome
by: Lynne Carty, et al.
Published: (2025)

Anxiety in the Pediatric Cystic Fibrosis Population: Evaluation of a Younger Cohort
by: Jemilla Strode Smith, et al.
Published: (2025)

Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
by: Chelsea Flora, et al.
Published: (2026)

Effects of Elexacaftor‐Tezacaftor‐Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis
by: Guillaume Petit, et al.
Published: (2025)

Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis
by: Gabriela R. Oates, et al.
Published: (2025)

Stakeholder Priorities for Cystic Fibrosis Mental Health Research: A Community and Provider Survey
by: Anna M. Georgiopoulos, et al.
Published: (2026)

Impact of Elexacaftor‐Tezacaftor‐Ivacaftor on Quality of Life in Children With Cystic Fibrosis
by: Sara Kümmerli, et al.
Published: (2026)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
by: Cindy L. Williams, et al.
Published: (2025)

Feeding the Need: A Study on Food Security Among People With Cystic Fibrosis in Turkey
by: Damla Kocaman, et al.
Published: (2025)

Plasma Microbial Cell‐Free DNA Metagenomic Next‐Generation Sequencing in People With Cystic Fibrosis
by: Mollie G. Wasserman, et al.
Published: (2024)

The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis
by: Aqeem Azam, et al.
Published: (2025)

Pathophysiology of Cystic Fibrosis Liver Disease
by: Vania L. Kasper, et al.
Published: (2024)

Roadmap to Global Cystic Fibrosis Care
by: Samya Z. Nasr, et al.
Published: (2025)

Cystic Fibrosis Year in Review 2024
by: Adrienne P. Savant
Published: (2025)

Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
by: Rebecca Gallardo, et al.
Published: (2026)

Acceptability of Telehealth Post‐Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis
by: Jaclyn Davis, et al.
Published: (2025)

C‐Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations
by: Jonathan B. Zuckerman, et al.
Published: (2025)

Development of a Simplified Arabic Questionnaire of Health‐Related Quality of Life for Children With Cystic Fibrosis
by: Heba A. Ali, et al.
Published: (2025)

Expanding Cystic Fibrosis Registries to the Rest of the World
by: Lutz Naehrlich
Published: (2026)

Real World Adverse Effects of Elexacaftor/Tezacaftor/Ivacaftor in People With Cystic Fibrosis Ages 6–11 Years
by: Rebecca S. Pettit, et al.
Published: (2025)

Disparities in Access to Cystic Fibrosis Therapy Across Countries
by: Bulent Karadag
Published: (2026)

“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
by: Tuğba Şişmanlar Eyüboğlu, et al.
Published: (2026)

Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis
by: Jordana E. Hoppe, et al.
Published: (2025)

A Joint Conversation: People With Cystic Fibrosis' Perception of Healthcare Teams' Knowledge, Comfort, and Barriers in Discussing Substance Use
by: Sanaz Vaziri, et al.
Published: (2025)

Survey Validation of Exercise and Body Composition Testing and Exercise Training Programs for People With Cystic Fibrosis: A Delphi Study
by: Najlaa Z. Alotaibi, et al.
Published: (2025)

Adherence to Anti‐Staphylococcal Prophylaxis in the First Two Years of Life and Microbiological Outcomes in the First Six Years of Life in Children With Cystic Fibrosis
by: Maryanne Holmes, et al.
Published: (2025)

Body Image Perceptions and Elexacaftor/Tezacaftor/Ivacaftor (ETI) Use in Adolescents and Young Adults Living With Cystic Fibrosis
by: Emma R. Lyons, et al.
Published: (2025)

Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
by: Laurie P. Murray, et al.
Published: (2025)

E‐Cigarettes and Cystic Fibrosis—Current Perceptions and Future Directions
by: Maryam Sahibqran, et al.
Published: (2024)

The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
by: Rebecca J. Vitale, et al.
Published: (2026)

Case Report: Alpha‐Gal Diagnosis in an Adolescent With Cystic Fibrosis
by: Sean Coyne, et al.
Published: (2024)

Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care
by: Brittany A. Wright, et al.
Published: (2025)

Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
by: Emma M. Tillman, et al.
Published: (2025)

Patient‐Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape
by: Suzanne Kroes, et al.
Published: (2026)